Anne Nunes
Chief Operating Officer chez ANIKA THERAPEUTICS, INC.
Fortune : 281 584 $ au 31/03/2024
Profil
Anne Nunes is currently the Chief Operating Officer & Senior Vice President at Anika Therapeutics, Inc. She previously worked as the Head of Research & Development at Eli Lilly & Co. and as the Senior Vice President of Global Operations at Smith & Nephew plc.
Ms. Nunes holds an MBA from Questrom School of Business and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANIKA THERAPEUTICS, INC.
0,08% | 15/03/2024 | 11 086 ( 0,08% ) | 281 584 $ | 31/03/2024 |
Postes actifs de Anne Nunes
| Sociétés | Poste | Début |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Chief Operating Officer | 01/09/2021 |
Anciens postes connus de Anne Nunes
| Sociétés | Poste | Fin |
|---|---|---|
| SMITH & NEPHEW PLC | Corporate Officer/Principal | 01/01/2021 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Formation de Anne Nunes
| Questrom School of Business | Masters Business Admin |
| University of Illinois At Urbana–Champaign | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ANIKA THERAPEUTICS, INC. | Health Technology |
| SMITH & NEPHEW PLC | Health Technology |
